and individual types of bacteria compete with each other for resources in the microenvironment, it is also likely that exposure to commensal fungi influences the immune system and that fungi compete with each other and with bacteria for resources. Bacterial dysbiosis may be an important feature of disease and so too might alterations in the mycobiota.
To understand the importance of interactions between the mycobiota and the host immune system we need to define the makeup of the mycobiota that is present in different locations of the body, and we need to understand the mechanisms by which the immune system interacts with fungi at mucosal surfaces. This Review focuses on efforts to identify the fungal microbiota at different sites, changes in fungal populations that occur during disease and how the immune system is thought to interact with specific fungi at various sites.
Fungi: an important part of the microbiota In the context of the entire microbiota, fungi are considered to be a minor component. In the gut, for example, recent shotgun sequencing efforts have suggested that fungi make up approximately 0.1% of the total microorganisms 5, 6 . There are several reasons to question whether this underestimates the number and importance of fungi. First, the estimates are based on identifying sequences by using available annotated reference sequences, and fungi are highly under represented in these databases compared with bacteria. For example, as of February 2014, the National Center for Biotechnology Information (NCBI) Genome database listed 57 complete Inflammatory bowel disease (IBD) . A group of chronic inflammatory conditions that affect the large and small intestine. The major types are Crohn's disease and ulcerative colitis.
Dysbiosis
A term that was originally coined by the 1908 Nobel laureate Eli Metchnikoff to refer to pathogenic alterations of the bacterial microflora in the gut. Now used more generally to refer to any microbial imbalance in or on the body at sites including the gastrointestinal tract, the skin and exposed mucosal surfaces such as the lungs, vagina or mouth.
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Abstract | The body is host to a wide variety of microbial communities from which the immune system protects us and that are important for the normal development of the immune system and for the maintenance of healthy tissues and physiological processes. Investigators have mostly focused on the bacterial members of these communities, but fungi are increasingly being recognized to have a role in defining these communities and to interact with immune cells. In this Review, we discuss what is currently known about the makeup of fungal communities in the body and the features of the immune system that are particularly important for interacting with fungi at these sites.
Shotgun sequencing
A sequencing approach in which a complex pool of DNA is broken up into random small segments that are sequenced en masse. Computational tools are then used to reassemble and characterize the DNA fragments.
Uncultured
A term that is used in mycobiome sequencing studies to refer to sequences that are identified in the National Center for Biotechnology Information GenBank database as fungal but that are currently of uncharacterized origin.
Candida
A genus of yeasts that includes common species such as Candida albicans, C. tropicalis, C. glabrata, C. parapsilosis and C. krusei. Candida species are normal inhabitants of the skin and mucous membranes and primarily cause disease in immunocompromised individuals. Candidiasis (disease caused by Candida) of the mouth or throat is called thrush or oropharyngeal candidiasis.
fungal genomes compared with >2,700 complete bacterial genomes. This suggests that fungi might be underdetected, compared with bacteria, in shotgun sequencing efforts. Second, a typical fungal cell (which is approximately 5 μm in diameter) is more than 100-fold larger than a typical bacterial cell (which is approximately 1 μm in diameter). Fungi are thus a much more substantial mass of biomaterials than is suggested simply by the number of available genomes. Third, as eukaryotes, fungi probably contribute unique metabolic features to the microbiota. Finally, recent studies have clearly demonstrated that even 'minor' components of the microbiota that proliferate in response to diet or during dysbiosis can have marked effects on the immune system [7] [8] [9] .
Approaches to studying the mycobiota. To study the myco biota and its interactions with the immune system, the fungal part of the microbiota needs to be identified and quantified. Early studies relied on culturing fungi from various anatomical sites but such methods made little progress in characterizing the full complexity of commensal fungal communities. DNA-based methods have enabled culture-independent detection and identification of fungi. Approaches such as restriction fragmentlength polymorphism (RFLP) analysis, oligo nucleotide fingerprinting of ribosomal RNA genes (OFRG) and denaturing gradient gel electrophoresis (DGGE) were good at revealing more complexity than culturing methods but were relatively poor at identifying specific fungi. The advent of new, affordable high-throughput sequencing technologies has made direct sequencing of fungal DNA the preferred method for characterizing the mycobiota. The most sensitive and affordable approach is to amplify a small variable region of fungal genomes in a sample by PCR, sequence many thousands or millions of these fragments and then identify each fragment by comparison to a database. Thus, the efficacy of the approach depends on the choice of fragment that is targeted. Common targets have been the 18S small-subunit ribosomal DNA (rDNA), 28S large-subunit rDNA or internal transcribed spacer regions
The quality of data that is obtained through sequencing rDNA fragments depends on having a comprehensive, well-annotated database of fungal sequences with which to compare the sequenced fragments. Whereas several excellent databases have been developed for identifying bacterial 16S rDNA sequences, this is still a formidable challenge for investigators that work with fungal sequences. The sequences that are available in the NCBI GenBank database probably only represent a proportion of the fungi that will be discovered; some estimates suggest that as little as 1% of fungal species are currently represented 10 . Furthermore, a large proportion of the available sequences are annotated as uncultured, which is not very useful for taxonomic purposes and, in addition, sequence annotations are plagued with misclassifications. It is estimated that 10-20% of sequences are misattributed 10 , and fungal taxonomy is currently in a state of enormous flux as sequencing data become available and more precise relationships between different fungi are characterized. Finally, it is very common for sexual and asexual forms of a fungus to be classified as different taxa
. In summary, there are formidable barriers to investigators who want to describe commensal fungal communities but many approaches are being developed to address these problems, and the development of better tools will lead to improvements in the detection of fungal species.
The intestinal mycobiota
Fungi are normal inhabitants of the mammalian gastrointestinal tract [11] [12] [13] [14] [15] [16] . Candida species have been successfully cultured from the intestines of healthy individuals, and increased colonization of the intestine with Candida species, as well as the production of antifungal antibodies (anti-Saccharomyces cerevisiae antibodies), have been seen in patients with inflammatory bowel disease (IBD) 17, 18 . Early culture-independent studies of the mouse mycobiota using OFRG revealed a highly diverse community of fungi in the mouse intestine 12 . In humans, DGGE analysis of 18S fungal rDNA has revealed differential fungal profiles between healthy individuals and patients with ulcerative colitis 19 . Whereas initial studies suggested that human and mouse intestines are populated by diverse fungal microbiota, the experimental approaches were labour intensive, marginally quantitative and could not be used to evaluate in-depth fungal variety. More recently, high-throughput sequencing approaches have been used to explore the fungal communities that populate both the human and mouse gut. These studies have shown that the gut is home to >50 genera of fungi with Candida, Saccharomyces and Cladosporium species being particularly common 13, 16 (FIG. 1) . With respect to Candida species, one study has reported that Candida tropicalis is common in mice 13 , whereas Candida albicans, Candida glabrata, Candida dubliniensis and Candida parapsilosis are the most prevalent species in humans [19] [20] [21] . Only a few of the most common gut fungi were found in mouse food, which suggests that the majority are indigenous to the intestine 13, 14 . A culturebased study on a remote population of Amerindian individuals found that colonization with C. albicans was
Box 1 | Fungal rDNA regions targeted for mycobiome characterization
The genomic region that encodes the fungal ribosomal DNA (rDNA) is shown in the figure. Certain structural regions of the rDNA are highly conserved and permit the synthesis of primers that will amplify fungal rDNA from nearly all species. There is considerable ongoing debate regarding which primer sets are optimal and which induce the least bias into the amplified sequence pool. As in other eukaryotes and bacteria, the rDNA region typically exists in multiple copies in each genome. In fungi, the locus is typically duplicated 100-200 times. As they are not part of the structural ribosomal RNAs that are transcribed from this region, the 'internal transcribed spacer' (ITS) regions are highly divergent between fungi (in sequence and in length), and they are often sufficiently different to classify fungi at the species level. This fungal rDNA region is the most heavily sequenced area in fungal genomes and nearly one-third of publically available fungal sequences are from this region. rare, whereas Candida krusei was the dominant Candida species, which suggests that there might be substantial heterogeneity in intestinal fungi between industrialized and non-industrialized societies, however this has yet to be comprehensively examined 22 . Studies in newborn mouse pups and in human infants have suggested that bacterial communities in the gut are initially unstable but become more stable in early childhood and develop more modestly throughout adulthood [23] [24] [25] . However, this may not be the case with the gut mycobiota. One recent study demonstrated that fungal populations in the mouse gut displayed episodic variation over several months, although the bacterial community remained relatively stable 14 . This suggests that commensal fungal populations are more variable than those of bacteria and that they may be influenced by fungi in the environment. Another explanation might be that bacteria are more abundant than fungi and, as a consequence, bacterial communities may be more robust than fungal communities. Alterations in diet can also affect the fungal microbiota; in humans, the consumption of a plantbased diet has been linked to an increase in gut colonization by Candida species, whereas the consumption of an animal-based diet facilitated the expansion of Penicillium species 15 .
Influence on bacterial microbiota. Fungal and bacterial communities undoubtedly influence each other. We have observed that commensal fungi in the mouse gut can be found in patches together with gut bacteria 13 . Germ-free mice are highly susceptible to Candida infection 26 , and antibiotic treatment supports colonization by and the overgrowth of Candida species in the mouse gut 14, 27, 28 . In one study, long-term antibiotic treatment (for 76 days) led to a robust expansion of fungi, so that they represented 99% of the total intestinal micro organisms that were detected by deep-sequencing analysis 14 . This was mostly due to an expansion of Candida species, which was the only genus that was found in the faeces by the end of the course of treatment. Prolonged antibiotic treatment in humans can predispose to fungal infections, which is mostly owing to the expansion of Candida species 29, 30 . This has been particularly evident in the treatment of patients with cancer and in paediatric intensive care units [31] [32] [33] . In keeping with the idea that fungi can also influence the bacterial composition of the gut microbiota, a recent study has demonstrated that the restoration of the bacterial microbiota after treatment with a single antibiotic (cefoperazone) was strongly influenced by colonization with C. albicans 34 . There were substantial decreases in the size of Bacteroidetes and Synergistetes populations, whereas Firmicutes populations remained unchanged. However, whether the Candida-induced perturbation of the microbiota is transient or long-lasting and how it affects the host remains to be elucidated.
Interactions with the immune system. We know little about if or how most intestinal commensal fungi interact with the host immune system, although many innate immune receptors have been shown to interact with fungal pathogens (FIG. 2) . There is ample evidence that host control of intestinal fungi is important, and various specific immune mechanisms have been implicated in the clearance of fungi from mucosal surfaces 35, 36 . Among these, C-type lectin domain family 7 member A (CLEC7A; also known as dectin 1), caspase recruitment domain-containing protein 9 (CARD9), interleukin-17 (IL-17) and IL-22 have emerged as molecules that are responsible for host defence against fungi, and genetic mutations in each of these molecules are associated with susceptibility to fungal infections in humans (TABLE 1) . We have reported that a genetic polymorphism in CLEC7A is associated with increased severity of ulcerative colitis in humans, and we have observed that experimental colitis in mice is more severe in the absence of CLEC7A 13 . The more severe colitis in mice was accompanied by fungal invasion of the colonic mucosa, as well as by a general expansion of populations of opportunistic fungi, such as Candida and Trichosporon species, and a decrease in non-pathogenic Saccharomyces species. In patients with IBD, the disease has been reported to be associated with an enrichment of Candida species (specifically C. dubliniensis and C. parapsilosis), which suggests that fungal dysbiosis may accompany disease 19 . However, the DGGE method that was used in this particular study was limited in its ability to fully characterize the fungal populations, and further studies applying more sensitive deep-sequencing analyses are needed.
A deficiency in CARD9 -which is a signalling molecule downstream of CLEC7A and other lectins that are involved in fungal recognition -has also been linked to susceptibility to IBD in humans [37] [38] [39] . Although CARD9 might be involved in signalling by other receptors, its specific importance in antifungal immunity is supported by the observation that individuals with rare
Box 2 | Sexual dimorphism in fungal taxonomy
Sexual dimorphism in fungi can be a major problem when classifying fungal sequences. Many fungi have a sexual (teleomorph) and an asexual (anamorph) form. Frequently, the two different forms have been given different names and they are often not even characterized as being in the same genus or family. To complicate matters further, many anamorph-teleomorph pairs have not been identified yet and are only being discovered when sequencing reveals that they are the same organism. When relying on public databases to identify fungi based on nucleotide sequences, this can become a considerable challenge. For example, genetically, Aspergillus glaucus and Eurotium herbariorum are the same organism, although internal transcribed spacer (ITS) sequences that are deposited in the National Center for Biotechnology Information (NCBI) GenBank database are equally split between the two names (see the table for examples). Public databases, including NCBI Taxonomy, can be used to try to resolve some of the known relationships but investigators can often get different taxonomy information depending on which database they use.
Anamorph Teleomorph
Fusarium graminearum (326 ITS sequences)
Gibberella zeae (257 ITS sequences) null mutations in CARD9 are specifically susceptible to fungal infection but not to other types of infection 40 . CARD9 deficiency in mice was shown to enhance susceptibility to experimental colitis, augment fungal burden in the gut, increase antifungal antibodies in the serum and cause wasting disease 41 . In addition, these mice can be partially rescued by antifungal treatment, which further supports a role for immunity to intestinal fungi in the pathogenesis of colitis 41 . IL-22 -which is a cytokine that is similar to IL-17 (discussed in more detail below) -is involved in mucosal immunity and has been directly implicated in controlling gastrointestinal fungi; mice that lack IL-22 are more susceptible to gastrointestinal candidiasis when infected intragastrically with C. albicans 42 . It has also been suggested that IL-22 production and anti-Candida immunity might be influenced by tryptophan metabolites 43 , which have a role in regulating commensal microbiota. Furthermore, effective host defence against Candida infection required IL-12 and interferon-γ (IFNγ), which indicates an important contribution of T helper 1 (T H 1) cell-mediated immunity. However, whether similar mechanisms are involved during an ongoing commensal relationship with C. albicans -which is a lifetime colonizer of the human gut -remains to be elucidated. Curiously, mouse models of colitis show that both IL-17A and IL-17F are dispensable for protection against gastrointestinal Candida species 42 . Striking evidence suggests that intestinal Candida species can influence immunity at distant body sites through both interactions with immune cells and the production of fungal metabolites. Antibiotic-induced Figure 1 | The human mycobiota. Complex populations of fungi have been found associated with the skin and all mucosal surfaces of the healthy human body. The pie charts indicate the relative proportions of fungal genera that are reported to be associated with the respective sites in representative fungal deep-sequencing studies. The fungal populations that are found on mucosal surfaces tend to be more diverse than those on the skin. The healthy lung probably reflects mostly environmental fungi, which are not included in the key. 'Others' refers to sequences that represent <1% of the total recovered sequences at each site. 'Uncultured' are sequences identified in the National Center for Biotechnology Information (NCBI) GenBank database as fungal but of uncharacterized origin. Data for pie charts were derived from studies of the fungal genera that are present in the oral cavity 50 , lungs 92 , colon 16 , vagina 79 and skin 70 . Nature Reviews | Immunology overgrowth of Candida species in the intestine has been shown to promote lung inflammation in a mouse model of allergy 27, 44 . Candida species (as well as many other fungi) directly produce prostaglandin E2 (PGE2) -a potent immunomodulator that is produced by immune cells -from host arachidonic acid, and it has been proposed that Candida-derived PGE2 might be involved in allergic inflammation [45] [46] [47] . Indeed it has recently been demonstrated that Candida-derived PGE2 can reach the lungs through the bloodstream, act on lung macrophages and promote allergic inflammation 48 . Similarly, an association between graft-versus-host disease and gut colonization with Candida species has been seen in transplant patients 49 . Gut colonization was correlated with the presence of a defective CLEC7A gene, which suggests that immune-mediated regulation of colonization may have an effect on peripheral tolerance.
Oral mycobiota
The oral cavity is a well-known site of microbial growth, although the fungal members of this community have rarely been assessed. A recent culture-independent evaluation of the mycobiota in the healthy mouth showed that the oral cavity is home to >75 different fungal genera Membrane-bound receptors -such as lectin receptors (which recognize fungal polysaccharides), Toll-like receptors (TLRs) and scavenger receptor family members -can directly recognize a wide variety of fungi or the soluble products that are released from fungi. These receptors trigger phagocytosis, respiratory burst (via the NADPH oxidase) and the killing of fungi, and also trigger intracellular signalling pathways that lead to the activation of transcription factors, such as nuclear factor-κB (NF-κB). These transcription factors induce the production of many pro-inflammatory cytokines and chemokines that are important for host defence against fungi. Fungi may also be recognized by soluble receptors, such as the mannosebinding lectin, which can direct complement activation for killing and the release of inflammatory mediators, as well as opsonize fungi for recognition by additional membrane-bound receptors, such as complement receptors. The question mark indicates that the signalling pathways downstream of many of these receptors remain to be elucidated. BCL-10, B cell lymphoma 10; CARD9, caspase recruitment domain-containing protein 9; CLEC, C-type lectin domain family member; IL, interleukin; IRAKs, IL-1 receptor-associated kinases; MALT1, mucosa-associated lymphoid tissue lymphoma translocation protein 1; MARCO, macrophage receptor; MINCLE, macrophage-inducible C-type lectin; MYD88, myeloid differentiation primary response protein 88; NLRP3, NOD-, LRR-and pyrin domain-containing 3; PGE2, prostaglandin E2; PTGES, prostaglandin E synthase; ROS, reactive oxygen species; SR-A, scavenger receptor type A; SREC, scavenger receptor expressed by endothelial cells; SYK, spleen tyrosine kinase; TNF, tumour necrosis factor; TRIF, TIR-domain-containing adaptor protein induced IFN-β. with Candida, Cladosporium, Aureobasidium, Aspergillus and Fusarium being among the most common 50 . A subsequent study reported that Malassezia and Epicoccum are also abundant 51 , although further studies will be required to understand the variability between these two studies. The nature of the host immune response to normal fungal carriage in the mouth has not been evaluated. However, it is well known that immunosuppressed individuals (such as patients with HIV or who are undergoing chemotherapy) frequently develop oropharyngeal candidiasis, which indicates that local immunity is necessary to contain Candida species. Whether local immunity influences colonization by or the growth of other fungal species is not known.
Genetic studies in humans provide some hints as to the types of immunity that are necessary for the healthy containment of Candida species in the mouth 52 . Chronic mucocutaneous candidiasis (CMC) is a condition that is characterized by recurrent Candida infections of the mouth, skin and other mucosal surfaces. Several groups have recently demonstrated that mutations in the signal transducer and activator of transcription 1 (STAT1) gene -which encodes a signalling molecule that is important for cellular responses to IFNγ, IL-17 and IL-22 -render patients highly susceptible to CMC with all cases exhibiting oral pathologies [53] [54] [55] [56] . In addition, mutations in the genes that encode IL-17RA, IL-17F and adaptor protein CIKS (also known as ACT1) -a protein that is 60, 61 . Together, these findings highlight the remarkably selective importance of T H 17 cellmediated immunity in restricting pathology caused by colonization with Candida species.
The innate responses that drive this T H 17 cellmediated immunity can also be inferred from genetic studies. Individuals with a genetic deficiency of CARD9 are highly susceptible to invasive Candida infections and typically have a history of oral infections 40, 62, 63 . Notably, patients with CARD9 deficiency showed decreased numbers of T H 17 cells 40 . In a mouse model of oral Candida infection, CARD9 was shown to be necessary for mounting a T H 17 cell response, although IL-17-dependent innate responses do not involve CARD9 (REF. 64 ). Of the receptors that could activate CARD9, CLEC7A has been shown to be important for effective oral anti fungal defence in a mouse model 65 . In humans, a common premature stop mutation in CLEC7A has been associated with onychomycosis but not with oropharyngeal candidiasis 66 . This might suggest that CLEC7A is not involved in oral antifungal immunity in humans, although the prevalence of the null mutation is sufficiently high that the penetrance of the effect must be low (even for onychomycosis) and nothing like the severity of the CARD9 mutations. Additional fungal-sensing receptors, such as CLEC6A, can signal through CARD9 (REF. 67) , and this redundancy might explain the more severe oral disease that is observed in the absence of CARD9. Further studies will be required to determine the role of additional receptors, such as CLEC6A, in oral antifungal immunity.
Skin mycobiota
The skin surface is the first point of contact of the body with environmental bacteria and fungi and it is home to billons of microorganisms that have developed a commensal relationship with the host. Deepsequencing approaches have demonstrated that the skin contains a unique bacterial and fungal microbiota [68] [69] [70] [71] [72] . Furthermore, the composition of the skin microbiota depends on the nature of the skin site, with certain patterns being associated with moist, dry or sebaceous microenvironments 68, 69 . As the skin is a self-renewing organ, dead cells are continuously shed, which provides an environment for saprophytic microbial growth.
Culture-dependent approaches have identified many commensal fungi that are present on the skin, with Malassezia as the most common genus, followed by Penicillium and Aspergillus 70, 73 . Other fungi -such as Alternaria, Candida, Rhodotorula, Cladosporium and Mucor -have also been cultured but with a lower frequency 70, 73 . Culture-independent sequencing studies have confirmed that the genus Malassezia is most commonly represented on healthy human skin across different body sites 70, 74, 75 . The higher resolution of these approaches has allowed the identification of specific species, and certain Malassezia species are associated with particular body sites 70 . Candida species were also detected across the body sites that were studied and were mostly represented by C. tropicalis, C. parapsilosis and C. orthopsilosis, which are different species from those that typically populate the human gut. Whereas sites on the foot revealed the greatest fungal diversity (40-80 genera), other sites -such as the nare, glabella, back, manubrium and palm -had greater bacterial diversity than fungal diversity 70 . This reverse correlation between the diversity of bacterial and fungal communities could be due to the presence of specific nutrients at different body sites and could point to a complex interaction between the two communities.
Patients with primary immunodeficiencies suffer from recurrent fungal infections. Although the immuno pathology of each specific immunodeficiency differs, a common hallmark is the development of atopic dermatitis-like eczema. One recent study in patients with primary immunodeficiencies revealed a direct link between host immunity and the skin bacterial and fungal microbiota 76 . Pathways involving STAT3 and dedicator of cytokinesis protein 8 (DOCK8; mutations of which cause hyper-IgE syndrome) and Wiskott-Aldrich syndrome protein (WAS; mutations of which cause Wiskott-Aldrich syndrome) were affected, and these patients exhibited an altered bacterial community structure, increased fungal diversity and an increased abundance of Candida and Aspergillus species in the skin 76 (TABLE 1) . Related results were obtained in another study, which showed that the diversity of non-Malassezia fungal microbiota is increased in patients with atopic dermatitis, with augmented representation of species of Candida, Cryptococcus and Cladosporium 75 . Analyses of the co-occurrence of specific bacteria and fungi have suggested that the two communities might interact 76 . STAT1 mutations that are associated with CMC have similarly been linked with alterations in the skin bacterial microbiota, although it is not yet known whether fungal diversity is affected 77 . An autosomal-recessive CARD9 mutation can lead to deep dermatophytosis, which, in contrast to a superficial mucocutaneous disease, affects dermal and sub cutaneous tissue, the lymph nodes and, occasionally, the central nervous system and can be fatal 62 . As noted above, these patients have decreased numbers of T H 17 cells 40 .
In vivo studies have shown that mice that are deficient in IL-17A or IL-23 are more susceptible to C. albicans skin infection 78 . Although IL-22 seems to have a role in mucocutaneous diseases in humans, it does not seem to be involved in the mouse model of Candida skin infection 78 . Future studies will be needed to elucidate the effect of the composition of the mycobiome on the immune responses that occur at specific body sites during skin disease. Vaginal mycobiota Like other mucosal surfaces, the vagina is home to a pool of microbial occupants that, if not properly contained, can cause pathologies. While yeast infections are common, several recent studies have revealed a more diverse population of resident fungi than has been previously appreciated [79] [80] [81] . These studies indicate the presence of 11-20 different genera, with commonly detected fungi including Candida, Saccharomyces, Aspergillus, Alternaria and Cladosporium. Changes in fungal diversity were found to be associated with diabetes, allergic rhinitis and recurrent vaginal candidiasis 80, 81 . Fungal growth is controlled both by other members of the local microbiota and by host immune defences. Lactobacilli species are the dominant microorganisms in the healthy vaginal microbiota 82 . These bacteria produce lactic acid that contributes to the low pH of the environment, which suppresses fungal growth, and they can compete with Candida species for binding to epithelial cells [82] [83] [84] . The idea that the immune system is responsible for normal surveillance of the vaginal fungal microbiota is suggested by the association of specific immune gene variants with recurrent vaginal candidiasis. Patients with a premature stop mutation in CLEC7A that is associated with onychomycosis also have recurrent vaginal candidiasis, which suggests that CLEC7A is important for normal containment of vaginal fungi 66, 85 . Another genetic variant for a length polymorphism in intron 4 of NLRP3 (which encodes NOD-, LRR-and PYD-domaincontaining protein 3; also known as NALP3) has also been associated with recurrent vaginal candidiasis 86 , which suggests that inflammasomes are important in the containment of vaginal fungi. Whereas an animal model of vaginal candidiasis has not been explored in the context of NLRP3, NLRP3-deficient mice are more susceptible to invasive disease in a model of mucosal Candida infection 65 . Furthermore, there is evidence to suggest a role for another inflammasome that contains NLR family CARD domain-containing protein 4 (NLRC4) in defence against oral C. albicans infection but whether this is also important in human immune defence or in vaginal fungal control is not known 87 . Mannose-binding lectin (MBL; also known as MBPC) is a soluble C-type lectin receptor (CLR) that binds to carbohydrates on microbial cell walls, activates the complement pathway and opsonizes microorganisms for phagocytosis. A genetic polymorphism in the gene that encodes MBL (MBL2) that affects the level of protein expression is associated with re current vaginal candidiasis, which suggests that MBL is important for normal containment of vaginal fungi [88] [89] [90] (TABLE 1). The MBL2 variant that is associated with low protein expression has also been reported to be associated with fungal infections at other mucosal sites, such as Aspergillus infection in the lung 91 .
Lung mycobiota
There is little evidence of a commensal fungal microbiota in healthy lungs, although the lungs are constantly exposed to oral and environmental fungi 92 . Thus, the mucosal immune system in the lungs continuously encounters fungi and fungal antigens. When normal lung function is compromised, such as in cystic fibrosis, the fungal communities may take hold and persist 93, 94 . Commonly encountered fungi in this setting include Aspergillus species and Scedosporium species, which are two spore-forming filamentous soil moulds that are widespread in the environment. Such spores are inhaled regularly and are normally cleared without pathology in immunocompetent individuals by alveolar macrophages that bind, internalize and kill the spores. Spores that evade killing can grow into hyphae which, if not killed, can invade the tissue, enter the circulation and disseminate 95 . Disseminated aspergillosis is particularly common in people who lack effective hyphal defence by polymorphonuclear phagocytes 95 . Aspergillus species are also a potent allergen, and colonization of the airways by Aspergillus species has been associated with severe asthma and nasal allergies 96 . Recognition of Aspergillus species in the lungs is mediated, in part, by pattern recognition receptors including CLECs (that is, CLEC6A and CLEC7A) and Toll-like receptors. Resting spores are encased in a waxy shell that shields them from recognition by most receptors but when the spores break this outer coating to germinate and grow as hyphae, multiple cell wall ligands are revealed [97] [98] [99] . This germination is thought to occur in the lumen of the lung but CLEC7A can also recognize Aspergillus spores that germinate after being ingested by macrophages in the lung 100 . In this case, the receptor is localized to phagosomes instead of the cell surface and is activated by the presence of the fungus. The central role of alveolar macrophages in the initial clearance of inhaled fungi is demonstrated in mice that express NADPH oxidase only in monocytes and macrophages. These animals clear Aspergillus normally, whereas mice that are fully deficient in NADPH oxidase are highly susceptible to Aspergillus infection 101, 102 . If fungi survive their first encounter with macrophages in the lungs, inflammatory infiltration of immune cells is initiated and the adaptive immune system may be engaged. T H 1-type T cell responses are generally protective against Aspergillus, whereas T H 2-type responses are generally associated with poor outcomes 103 . However, some reports suggest that T H 17 cell responses are even more important than T H 1 cell responses in this setting. Indeed, it was shown that CLEC7A signalling specifically is important for decreasing T H 1 responses and promoting T H 17 cell responses to Aspergillus infection 104 . Also, CLEC7A is important for stimulating the production of IL-22, which is a T H 17 cell-associated cytokine with pro-inflammatory and anti-inflammatory properties 105 . Furthermore, CLEC6A has been shown to have an important role in regulating IL-17 production by a subset of retinoic acid receptor-related orphan receptor-γt (RORγt)-expressing neutro phils in response to Aspergillus infection, which indicates that these innate cells may be an important source of IL-17 during infection 106 , however this has not yet been specifically examined in the case of exposure to fungi in the lungs.
Just as important as mounting effective immune responses against fungi in the lungs is the need to prevent allergic inflammation in response to fungal antigens. Allergic responses to Aspergillus in a mouse model were shown to be highly dependent on CLEC7A-mediated recognition of the fungus and the ability of this receptor to promote IL-22 production by T cells 107 . However, the mechanisms that promote allergic inflammation are probably highly dependent on the type of fungus, as indicated by the observation that although responses to are Aspergillus promoted by CLEC7A, responses to Cladosporium species were shown to be independent of CLEC7A and IL-17 (REF. 108 ). As noted above, commensal fungi in the gut may have a substantial impact on the nature of inflammation in the lungs 27, 44 . The precise mechanism by which this occurs and whether it preferentially affects responses to fungal triggers are important issues that remain to be fully explored. It is possible that the PGE2 that is produced by intestinal fungi influences macrophages in the lungs [45] [46] [47] [48] . Nature Reviews | Immunology 
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Figure 3 | Mucosal immune responses involved in interacting with fungi at different body sites. Different body sites are colonized by diverse groups of fungi and the communities are shaped by the characteristics of each environment. Epithelial cells at these surfaces produce antimicrobial peptides that directly modulate fungal survival. In response to fungi, cytokines and chemokines are also produced and these recruit immune cells to the site. Fungi may also be directly sensed by dendritic cells (DCs) and γδ T cells at epithelial surfaces. When epithelial barriers are breached, macrophages, DCs and neutrophils kill fungi and produce cytokines that promote adaptive immune responses. Innate lymphoid cells (ILCs) may also respond directly to fungi by producing cytokines. Genetic studies in humans have revealed key proteins that are particularly important for antifungal defence and that implicate a crucial role for the interleukin-17 (IL-17) pathway in this process. CARD9, caspase recruitment domain-containing protein 9; CLEC7A, C-type lectin domain family 7 member A; DOCK8, dedicator of cytokinesis protein 8; IL-12RB1, IL-12 receptor subunit β1; IL-17RA, IL-17 receptor A; MBL, mannose-binding lectin; NKT cell, natural killer T cell; REGIIIγ, regenerating islet-derived protein IIIγ; STAT, signal transducer and activator of transcription; T H 17, T helper 17.
a-α mating type
This refers to two haploid sexual forms of yeast. The a-type yeast cells secret an 'a-factor', which is a pheromone that attracts the α-mating type, which, in turn, secretes 'α-factor' . The a-type cells respond to the α-factor by growing a projection (shmoo) towards the α-cells. Haploid cells respond only to a pheromone of the opposite cell type, which allows for mating to only occur between a-type and α-type cells.
Conclusions
Just as the body is host to diverse populations of bacteria that contribute to health and pathology, so too is the body host to diverse populations of fungi that have been less well studied. Commensal fungal populations vary between body sites and probably also vary over time and with disease. It will be interesting in coming years to learn more about how the immune system specifically interacts with the mycobiota in health and disease. The molecular and cellular mechanisms that engage specific fungi during steady-state healthy conditions may be quite different from those that are engaged in diseased tissue or during active fungal invasion. The health of tissues and tissue barriers might influence this but so too might the fungi themselves. For example, Candida species are a di morphic fungi and they can grow in yeast and hyphal forms. This ability to switch between morphologies affects its pathogenicity, and several reports have demonstrated that the yeast and hyphal forms are recognized differently by immune cells [109] [110] [111] [112] [113] [114] . A recent study has demonstrated that commensal C. albicans in the intestine takes on an entirely novel morphology termed gastrointestinally-induced transition (GUT) that is related to the a-α mating type 115 . GUT Candida cells are metabolically adapted to take advantage of nutrients that are available in the gut and they have an attenuated ability to induce systemic disease in a mouse model of bloodstream Candida infection, but it is not known whether they interact with immune cells in ways that are fundamentally different from other forms of Candida.
Each mucosal surface is a unique environment that shapes the microbiota that inhabits the site. Current studies have documented that, like bacteria, diverse populations of fungi are characteristic to specific sites of the body. The local immune system at each site might interact with commensal fungi in similar or unique ways (FIG. 3) . Future studies will be required to understand how the mucosal immune system interacts with fungal communities and how we might exploit these interactions to prevent or treat fungal and inflammatory diseases.
